Dáil debates

Wednesday, 28 January 2015

12:25 pm

Photo of Enda KennyEnda Kenny (Mayo, Fine Gael) | Oireachtas source

It costs €420,000 extra per annum, per patient. The Health Service Executive is right to engage with the drugs company because it is the body that must deal with drug pricing and reimbursement for drugs. The HSE has concluded those negotiations. In view of the fact that this matter was raised by Deputy McEntee, Alexion Pharma-----

Comments

No comments

Log in or join to post a public comment.